Status:
COMPLETED
Nonalcoholic Fatty Liver Disease is Associated With Increased Atrial Fibrillation Risk in an Elderly Chinese Population
Lead Sponsor:
Ningbo No. 1 Hospital
Conditions:
Nonalcoholic Fatty Liver Disease
Atrial Fibrillation
Eligibility:
All Genders
65-100 years
Brief Summary
Atrial fibrillation and nonalcoholic fatty liver disease are two pathological conditions that are highly prevalent worldwide and share multiple CVD risk factors. There is rare research performed among...
Detailed Description
Because of the aging population and improvements in cardiovascular treatments, its prevalence is expected to increase substantially over the next few decades. AF has been reported to be associated wit...
Eligibility Criteria
Inclusion
- those who undergone an annual physical examination at Zhenhai Lianhua Hospital, Ningbo, China in 2014
- elderly adults (≥65 years old)
Exclusion
- unknown alcohol intake or excessive alcohol intake
- unknown BMI or BMI≤18.0kg/m2
- incomplete basic physical data
- missing liver ultrasonic diagnosis
- unknown causes of chronic liver disease
Key Trial Info
Start Date :
December 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2018
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03366987
Start Date
December 12 2017
End Date
January 30 2018
Last Update
June 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ningbo NO.1 hospital
Ningbo, Zhejiang, China, 315010